www.therabionic.com

The TheraBionic P1 medical device is indicated for the systemic treatment of ... and cofounders of TheraBionic Inc., formerly TheraBionic LLC, and TheraBionic ...

www.therabionic.com/therapy-with-the-therabionic-p1-medical-device

2011) Thus, better outcome in the Costa et al. study cannot, therefore, be attributed to better general ... Progression Free Survival - TheraBionic vs Placebo  ...

jeccr.biomedcentral.com/articles/10.1186/1756-9966-28-51

Apr 14, 2009 ... Alexandre Barbault,; Frederico P Costa,; Brad Bottger,; Reginald F Munden,; Fin Bomholt,; Niels Kuster and; Boris PascheEmail author. Journal ...

www.nature.com/articles/bjc2011292

Aug 9, 2011 ... F P Costa; , A C de Oliveira; , R Meirelles; , M C C Machado; , T Zanesco .... of 10 % for the null hypothesis of a 6-month PFS rate of 10% vs the alternative of 27.5 %. ..... AB and BP are founding members of TheraBionic LLC.

www.bioscience.org/2018/v23/af/4591/2.htm

Jan 1, 2018 ... NovocureTM and TherabionicTM: Two Novel Modalities for Cancer Treatment: 5.1. ..... Building upon their findings from 2009, Costa et al. conducted a ... Using tumor-specific RF EMF vs control exposure, comprised of randomly chosen .... Barbault hold stocks in TheraBionic LLC and TheraBionic GmbH. 8.

ascopubs.org/doi/abs/10.1200/JCO.2018.36.4_suppl.332

Feb 26, 2018 ... (Costa FP, et al. Br J Cancer. 2011;105:640-648.) The mechanism by which AM RF EMF have direct antiproliferative effect and disruption of the ...

directory.ncbiotech.org/content/therabionic-inc

TheraBionic is developing treatment approaches for cancer based on the use of tumor-specific modulation frequencies, with an initial focus in hepatocellular ...

microwavenews.com/news-center/very-weak-rf-signals-show-promise-treating-inoperable-liver-cancer

Aug 15, 2011 ... Costa and Pasche's new findings were published by the British Journal ... Not only could this new therapy, called TheraBionic, revolutionize the ...

www.researchgate.net/publication/24277597_Barbault_A_Costa_F_Bottger_B_Munden_R_Bomholt_F_Kuster_N_Pasche_BAmplitude-modulated_electromagnetic_fields_for_the_treatment_of_cancer_discovery_of_tumor-specific_frequencies_and_assessment_of_a_nove

Barbault A, Costa F, Bottger B, Munden R, Bomholt F, Kuster N, Pasche BAmplitude-modulated ... Frederico P Costa. + 3 ..... (median, 61 years) and 75% (n = 21) had PS of 1 (vs 0 or ..... AB and BP are founding members of TheraBionic LLC.